Evidence map›Paper›PMID 39641920›Full record

ArticleACS chemical biology2024

Bioorthogonal Cyclopropenones for Investigating RNA Structure.

Sharon Chen, Christopher D Sibley, Brandon Latifi, Sumirtha Balaratnam, Robert S Dorn, Andrej Lupták, John S Schneekloth, Jennifer A Prescher

Abstract readLetter
In one paragraph

Article in ACS chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sharon Chen
Christopher D SibleyChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
Brandon Latifi
Sumirtha BalaratnamChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
John S SchneeklothChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
Jennifer A PrescherORCID 0000-0002-9250-4702

Funding

Cyclopropenones to assemble, analyze, and activate biomoleculesR01GM126226 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PRESCHER, JENNIFER · 2018 to 2021
$1.1M
NIGMS NIH HHS R01 GM126226
6 · The paper itself

Abstract

RNA sequences encode structures that impact protein production and other cellular processes. Misfolded RNAs can also potentiate disease, but a complete picture is lacking. To establish more comprehensive and accurate RNA structure-function relationships, new methods are needed to interrogate RNA in native environments. Existing tools rely primarily on electrophiles that are constitutively "on" or triggered by UV light, often resulting in high background. Here we describe an alternative, chemically triggered approach to cross-link RNAs using bioorthogonal cyclopropenones (CpOs). These reagents selectively react with phosphines to provide ketenes─electrophiles that can trap neighboring nucleophiles to forge covalent cross-links. As a proof-of-concept, we conjugated a CpO motif to thiazole orange (TO-1). TO-1-CpO bound selectively to a model RNA aptamer (Mango) with nanomolar affinity, as confirmed by fluorescence turn-on. After phosphine administration, covalent cross-links were formed between the CpO and RNA. Cross-linking was both time and dose dependent. We further applied the chemically triggered tools to model RNAs under biologically relevant conditions. Collectively, this work expands the toolkit of probes for studying RNA and its native conformations.

Indexed as

CyclopropanesRNAAptamers, NucleotideBenzothiazolesCross-Linking ReagentsNucleic Acid ConformationPhosphinesQuinolinesAptamers, NucleotideBenzothiazolesCross-Linking ReagentsCyclopropanescyclopropenonePhosphinesQuinolinesRNAthiazole orange

Identifiers

PMID39641920
PMCPMC11667673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.